Spring Hill, KS, United States of America

Dan Keil



 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2015-2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Dan Keil

Introduction

Dan Keil is an accomplished inventor based in Spring Hill, Kansas, known for his significant contributions to the field of immunology. With a focus on cross-reactive determinants, his work has led to the development of innovative methods and compositions that have the potential to impact diagnostics and treatment of infectious diseases.

Latest Patents

Dan Keil holds 2 patents that showcase his expertise in identifying immunologically cross-reactive molecules. His latest patents include compositions and methods for determining proteins that comprise cross-reactive antigenic determinants. These inventions are particularly valuable for diagnosing and treating diseases associated with infectious microorganisms. The patents provide methods for preventing or treating various conditions linked to infections, highlighting the importance of his work in the medical field.

Career Highlights

Throughout his career, Dan has worked with notable companies such as Elanco Tiergesundheit AG and Novartis Tiergesundheit AG. His experience in these organizations has allowed him to collaborate with leading professionals in the industry and contribute to groundbreaking research.

Collaborations

Dan has had the opportunity to work alongside talented individuals such as Thomas Plocher and Manuel Campos. These collaborations have enriched his research and have played a crucial role in the development of his innovative patents.

Conclusion

Dan Keil's contributions to the field of immunology through his patents and collaborations demonstrate his commitment to advancing medical science. His work continues to pave the way for new diagnostic and treatment methods for infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…